Chronic liver disease-related mortality during the COVID-19 pandemic
Donghee Kim(Chungnam National University), Aijaz Ahmed(Stanford University), Karn Wijarnpreecha(University of Arizona), Richie Manikat(Stanford University), George Cholankeril(Baylor College of Medicine)
Cited by 1
Related Papers
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
|The Lancet|2019|1.2k
Nonobese Fatty Liver Disease
|Clinical Gastroenterology and Hepatology|2016|346
Current epidemiology of chronic liver disease
|Gastroenterology report|2023|56
Hepatitis E in solid organ transplant recipients: A systematic review and meta-analysis
|World Journal of Gastroenterology|2021|41
Nonalcoholic fatty liver disease and non-liver comorbidities
|Clinical and Molecular Hepatology|2023|37